Replimune Group, Inc. reports results for the quarter ended September 30 - Earnings Summary

By Reuters News
  • Replimune Group, Inc. reported a quarterly adjusted loss of 54 cents​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -90 cents. The mean expectation of eight analysts for the quarter was for a loss of 77 cents per share. Wall Street expected results to range from -92 cents to -60 cents per share.

  • Reported revenue was zero​; analysts expected zero.

  • Replimune Group, Inc.'s reported EPS for the quarter was a loss of 54 cents​.

  • The company reported a quarterly loss of $57.12 million.

  • Replimune Group, Inc. shares had fallen by 1.4% this quarter and gained 34.3% so far this year.

FORECAST CHANGES

  • The mean earnings estimate of analysts had fallen by about 16.2% in the last three months.​

  • In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," no "hold" and 1 "sell" or "strong sell."

This summary was machine generated from LSEG data October 28 at 01:32 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Sep. 30 2026

-0.77

-0.54

Beat

Jun. 30 2026

-0.72

-0.72

Met

Mar. 31 2026

-0.71

-0.76

Missed

Dec. 31 2025

-0.89

-0.77

Beat

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk